Concise Manual of Hematology and Oncology

1. Front Matter

   Pages I-XXI

   PDF

2. Principles of Medical Oncology

   • Dietmar P. Berger, Hartmut Henß, Uwe Martens, Hartmut Bertz, Monika Engelhardt, Sebastian Fetscher

   Pages 1-38

3. Special Diagnostics

   • Regina Kunzmann, Michael Luebbert, Hendrik Veelken, Jürgen Scheele, Uwe Martens, Rupert Engelhardt et al.

   Pages 39-64

4. Pharmacology and Pharmacotherapy

   • Dietmar P. Berger, Rupert Engelhardt, Hartmut Henß, Jürgen Scheele, Claudia I. Müller, Alexandra Göbel et al.

   Pages 65-203

5. Supportive Treatment

   • Michael Daskalakis, Hartmut Bertz, Veronique Thierry, Claudia I. Müller, Monika Engelhardt, Antonia Müller et al.

   Pages 204-292

6. Particular Treatment Procedures

   • Barbara Deschler, Cornelius Waller, Monika Engelhardt, Antonia Müller, Michael Luebbert, Jürgen Finke et al.

   Pages 293-326

7. Hematology and Hemostasis

   • Jürgen Finke, Hartmut Bertz, Anna-Katharina Kaskel, Jürgen Heinz, A.K. Thomas, Dietmar P. Berger et al.

   Pages 327-399

8. Hematological Neoplasia

   • Ralph Waesch, Werner Digel, Michael Luebbert, Kristina Heining-Mikesch, Cornelius Waller, W. Lange et al.

   Pages 400-526

9. Medical Oncology

   • Michael Daskalakis, Karl Henne, Hartmut Henß, Uwe Martens, Werner Digel, Rupert Engelhardt et al.

   Pages 528-780

10. Hematological and Oncological Emergencies

    • Hartmut Bertz, Hartmut Henß, Beate Lubrich

    Pages 781-801

11. Standard Operating Procedures (SOP)

    • Rupert Engelhardt, Andrea Engelhardt, Frank Gärtner, Stephan Mielke, Uwe Frank

    Pages 802-822

12. Standardized Treatment Protocols

    • D. Behringer, Dietmar P. Berger, Werner Digel, Monika Engelhardt, Jürgen Finke, Hartmut Bertz et al.

    Pages 823-989

13. Back Matter

    Pages 991-1002

    PDF

How Do We Treat? Hematology and Oncology have seen rapid progress and advances during recent years. Increased knowledge of tumor biology, epidemiology, molecular genetics, growth reg- lation, and cellular functions has led to novel therapeutic paradigms. Targeted trea- ment approaches, antibodies, immunotherapy, and other new techniques complement classic chemotherapy, radiotherapy, and surgery. Patients are increasingly well educated as web-based information on diagnostic and therapeutic options as well as quality ma- agement and tumor outcome data are readily available. In this dynamic and fast-paced environment, it is of central importance to base clinical decisions and medical practice on the best available evidence. Continuous quality ma- agement, with clinical process documentation, standardization, and evaluation, leads to improved patient care and long-term outcomes. For these reasons, we have started to systematically capture and evaluate data on diagnosis, treatment, and outcomes of p- tients with solid tumors and hematological neoplasms at the Freiburg University Med- cal Center. We have developed standard operating procedures, clinical pathways, and diagnostic and therapeutic processes, following the principles of “Good Clinical Pra- tice.” Tese processes (e.g., detailed protocols for chemotherapy application, treatment fowcharts, clinical pathways) are continuously tested and validated in clinical practice.

• Cancer
• Chemotherapy
• Hematology
• Oncology
• diagnostics

• Department of Hematology and Oncology, University Medical Center, Freiburg, Germany

  Dietmar P. Berger, Monika Engelhardt, Roland Mertelsmann

• Tumorzentrum Ludwig-Heilmeyer, Comprehensive Cancer Center, University Medical Center, Freiburg, Germany

  Hartmut Henß

Policies and ethics